The World Health Organization established a new international forum designed to strengthen transparency around clinical‑trial reporting and to promote the generation of high‑quality evidence for health decision‑making. The forum will convene regulators, sponsors, trial registries and researchers to align standards and best practices. WHO communications indicate the effort targets systemic gaps in trial result disclosure and aims to reduce research waste and selective reporting. The body will emphasize accessible registries, standardized reporting timelines, and accountability mechanisms. For industry, the initiative signals increasing global scrutiny of trial conduct and reporting expectations that may affect regulatory interactions, sponsor reputations and patient trust in clinical research.